In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - January 13, 2023 Category: Cancer & Oncology Authors: Tao Xu Philipp Karschnia Bruno Loureiro Cadilha Sertac Dede Michael Lorenz Niklas Seewaldt Elene Nikolaishvili Katharina M üller Jens Blobner Nico Teske Julika J. Herold Kai Rejeski Sigrid Langer Hannah Obeck Theo Lorenzini Matthias Mulazzani Wenlong Zha Source Type: research
Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - January 8, 2023 Category: Cancer & Oncology Authors: Nicole L. Edmonds Sarah E Gradecki Priya Katyal Kevin T Lynch Anne M Stowman Alejandro A Gru Victor H Engelhard Craig L Slingluff Ileana S. Mauldin Source Type: research
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - January 8, 2023 Category: Cancer & Oncology Authors: Prabha Shrestha Yana Astter David A. Davis Ting Zhou Constance M. Yuan Ramya Ramaswami Hao-Wei Wang Kathryn Lurain Robert Yarchoan Source Type: research
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - January 5, 2023 Category: Cancer & Oncology Authors: Fulong Wang Shixun Lu Di Cao Juanjuan Qian Cong Li Rongxin Zhang Feng Wang Miaoqing Wu Yifan Liu Zhizhong Pan Xiaojun Wu Zhenhai Lu Peirong Ding Liren Li Junzhong Lin Aur élie Catteau J érôme Galon Gong Chen Source Type: research
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - January 5, 2023 Category: Cancer & Oncology Authors: Camille Bigenwald Yacine Haddad Cassandra Thelemaque Agathe Carrier Roxanne Birebent Pierre Ly Caroline Flament Imran Lahmar Eric de Sousa Markus Maeurer Makoto Miyara Tarek Assi Cristina Castilla-Llorente Christophe Willekens C éline Fayemi Julien Lazar Source Type: research
Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 27, 2022 Category: Cancer & Oncology Authors: Jun Deng Hui Ke Source Type: research
Altered phenotypic and metabolic characteristics of FOXP3+CD3+CD56+ natural killer T (NKT)-like cells in human malignant pleural effusion
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 22, 2022 Category: Cancer & Oncology Authors: Zi-Hao Wang Pei Zhang Wen-Bei Peng Lin-Lin Ye Xuan Xiang Xiao-Shan Wei Yi-Ran Niu Si-Yu Zhang Qian-Qian Xue Hao-Lei Wang Qiong Zhou Source Type: research
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 22, 2022 Category: Cancer & Oncology Authors: Gloria Esteso Mar ía José Felgueres Álvaro F. García-Jiménez Christina Reyburn-Val és Alberto Bengur ía Enrique V ázquez Hugh T. Reyburn Nacho Aguil ó Carlos Mart ín Eugenia Puentes Ingrid Murillo Esteban Rodr íguez Mar Val és-Gómez Source Type: research
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 22, 2022 Category: Cancer & Oncology Authors: Pierre-Antoine Laurent Daphne Morel Lydia Meziani Stephane Depil Eric Deutsch Source Type: research
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 18, 2022 Category: Cancer & Oncology Authors: Loulieta Nazerai Shona Caroline Willis Patricio Yankilevich Luca Di Leo Francesca Maria Bosisio Alex Frias Corine Bertolotto Jacob Nersting Maria Thastrup Soren Buus Allan Randrup Thomsen Morten Nielsen Kristoffer Staal Rohrberg Kjeld Schmiegelow Daniela Source Type: research
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 18, 2022 Category: Cancer & Oncology Authors: Bao-Tram Thi Tran Aurore Gelin Sylv ère Durand Matthieu Texier Amaury Daste Cl émence Toullec Karim Benihoud Ingrid Breuskin Philippe Gorphe Florence Garic Catherine Brenner Christophe Le Tourneau J érôme Fayette Toshiro Niki Muriel David Pierre Busso Source Type: research
ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 16, 2022 Category: Cancer & Oncology Authors: Guanpeng Wang Yeni Romero Indhujah Thevarajan Anna Zolkiewska Source Type: research
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 15, 2022 Category: Cancer & Oncology Authors: Julia Koerner Dennis Horvath Franziska Oliveri Jun Li Michael Basler Source Type: research
Cellular senescence enhances adaptive anticancer immunosurveillance
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 15, 2022 Category: Cancer & Oncology Authors: Ines Marin Manuel Serrano Federico Pietrocola Source Type: research
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
Volume 12, Issue 1, December 2023 . (Source: OncoImmunology)
Source: OncoImmunology - December 15, 2022 Category: Cancer & Oncology Authors: Christoforos K. Vaxevanis Marcus Bauer Karthikeyan Subbarayan Michael Friedrich Chiara Massa Katharina Biehl Haifa Kathrin Al-Ali Claudia Wickenhauser Barbara Seliger Source Type: research
